Future Outlook of the Biosimilar Growth Hormones Market: Growth, Trends, and Emerging Opportunities Explored
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the biosimilar growth hormones market grown in recent years?
The market size of biosimilar growth hormones has been experiencing substantial growth in the past few years. It is projected to expand from $0.76 billion in 2024 to a higher value of $0.82 billion in 2025, developing at a compound annual growth rate (CAGR) of 8.4%. The historical period’s growth can be linked to the escalated demand for growth hormones, the expiration of patents, clinically proven evidence, and a rise in clinical trials.
How is the biosimilar growth hormones market size expected to evolve during the forecast period?
The market size for biosimilar growth hormones is projected to experience robust expansion in the coming years, with an anticipation to reach $1.19 billion by 2029, and a Compound Annual Growth Rate (CAGR) of 9.8%. This expected growth during the forecast period could be due to numerous factors such as the prevalence of pediatric growth disorders, widening indications, an uptick in diagnosis, and an enhanced cognizance regarding biosimilar options. Upcoming trends during this forecast period may comprise cycles of pediatric-focused biosimilars, mixtures of biosimilars, convenience in dosing, along with repeated instances of biosimilar combinations and dosing convenience.
Get your biosimilar growth hormones market report here!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp
Which key drivers are propelling the biosimilar growth hormones market’s growth?
The surge in the biosimilar growth hormone market worldwide is being steered by the increasing cases of kids struggling with growth hormone insufficiency. Damage to the pituitary gland or hypothalamus results in growth hormone deficiency, which might be congenital (abnormal formation before birth) or acquired (occurred during or after birth). For example, Hormones Australia run by the Endocrine Society of Australia (ESA) – a national body for the treatment of endocrine-based conditions – revealed in September 2023 that 2 to 3 out of every 10,000 people suffer from growth hormone deficiency. Hence, the escalation in children affected by growth insufficiencies propels the expansion of the biosimilar growth hormones market.
What are the market segments in the biosimilar growth hormones industry?
The biosimilar growth hormones market covered in this report is segmented –
1) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics
Subsegments:
1) By Intravenous: Hospital-based Administration, Outpatient Clinics
2) By Subcutaneous: Self-administration, Professional Administration
3) By Intramuscular: Pediatric Care, Adult Care
4) By Oral: Tablets, Capsules
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp
Which leading companies are shaping the growth of the biosimilar growth hormones market?
Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation
What key trends are currently impacting the biosimilar growth hormones market’s development?
Leading firms active in the biosimilar growth hormones market are developing new solutions like human growth hormone to improve the effectiveness and cost-effectiveness of treatments for growth hormone deficiencies. Growth hormone solutions are therapeutic interventions or supplements created to stimulate or replace human growth hormone (HGH) in the body for growth deficiencies or for purposes of anti-aging. For example, in June 2023, Pfizer Inc., a pharmaceutical firm based in the US, and OPKO Health Inc., a US-based healthcare company, received approval from the US Food and Drug Administration (FDA) for NGENLA (somatrogon-ghla). This is a human growth hormone treatment that is injected once a week and is intended for pediatric patients with growth hormone deficiency (GHD). This extensive-acting growth hormone treatment provides an alternative to everyday injections, potentially enhancing patient and caregiver compliance and convenience. The approval was granted based on clinical studies which showed that it is effective and safe, thereby marking a significant progression in growth hormone treatments.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3391
Which geographic areas are influencing the growth of the biosimilar growth hormones market?
North America was the largest region in the biosimilar growth hormone market in 2024. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Biosimilar Hormones Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
Biosimilar Monoclonal Antibodies Global Market Report 2024
Biosimilar Therapeutic Peptides Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
